logo-large
  • Browse Categories

Publications by authors named "Martin Lachnit"

Claim this Profile
O
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID-19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic.
Ondrej Šušol, Barbora Šušolová, Ondřej Klempíř, Milan Navrátil, Jaromír Gumulec, Martin Lachnit

Cancer Med· December 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoablative therapy followed by autologous hematopoietic stem cell transplantation as the first-line disease-modifying therapy in patients with multiple sclerosis.
Martin Lachnit, Kamila Zondra Revendova, Pavel Hradilek, Radovan Bunganic, Zdenek Koristek

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· March 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of miR-126 in Critical Limb Ischemia Treatment Using Adipose-Derived Stem Cell Therapeutic Factor Concentrate and Extracellular Matrix Microparticles.
Václav Procházka, Jana Jurčíková, Kateřina Vítková, Lubomír Pavliska, Ludmila Porubová, Martin Lachnit

Med Sci Monit· January 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: